AR and prostate carcinoma: LNCaP cells are originally derived from the lymph node metastasis of a patient with prostate cancer positive for androgen receptor (AR) whereas VCaP cells are established from vertebral bone metastasis from a patient with hormone refractory PCa expressing AR and AR-splice variants.